Pilot efficacy and tolerability: A randomized, placebo‐controlled trial of levetiracetam for essential tremor
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The purpose of this pilot single‐site study was to assess efficacy and safety of levetiracetam for essential tremor, using a placebo‐controlled, double‐blind, randomized crossover design with an interim analysis planned after completion of the first 10 to 15 subjects. The study was designed to detect a mean 30% reduction in composite tremor score, comparable to that of primidone or propranolol, which can be demonstrated with 30 or fewer subjects. Each treatment arm included baseline tremor assessments, a 4‐week medication titration, 2 weeks of stable dose, and treatment tremor assessments. Levetiracetam was titrated to 3,000 mg/day or to a lower maximal tolerated dose. The median age was 72 years, with 28 years median tremor duration. There was no statistically significant difference in response between placebo and levetiracetam on any tremor rating scale or accelerometry measure. The 95% confidence interval for the true mean difference between placebo and levetiracetam treatments was +18.5 to −22.5%, which excludes the minimum 30% drop required to consider levetiracetam clinically effective to a degree comparable to primidone or propranolol. Whether levetiracetam has lesser‐degree antitremor efficacy was not addressed in this pilot study. © 2004 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jankovic, J., Schwartz, K., Clemence, W., Aswad, A., & Mordaunt, J. (1996) · Movement Disorders · doi:10.1002/mds.870110306 · Cited by 235
Cited by
Treatment of patients with essential tremor
Deuschl, G., Raethjen, J., Hellriegel, H., & Elble, R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70322-7 · Cited by 428
Zesiewicz, T. A., Elble, R. J., Louis, E. D., Gronseth, G. S., Ondo, W. G., Dewey, R. B., Okun, M. S., Sullivan, K. L., & Weiner, W. J. (2011) · Neurology · doi:10.1212/wnl.0b013e318236f0fd · Cited by 348
Johannessen Landmark, C. (2008) · CNS Drugs · doi:10.2165/00023210-200822010-00003 · Cited by 316
Transducer‐based evaluation of tremor
Haubenberger, D., Abbruzzese, G., Bain, P. G., Bajaj, N., Benito‐León, J., Bhatia, K. P., Deuschl, G., Forjaz, M. J., Hallett, M., Louis, E. D., et al. (2016) · Movement Disorders · doi:10.1002/mds.26671 · Cited by 87
Pharmacological Treatments of Tremor
Grimaldi, G., & Manto, M. (2013) · Contemporary Clinical Neuroscience · doi:10.1007/978-1-4614-4027-7_23 · Cited by 3
Metadata
- Authors
- Handforth, A., & Martin, F. C.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2004-05-13
- Volume
- 19
- Issue
- 10
- Pages
- 1215-1221
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2001408934
- Cited by
- 50
- References
- 1
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pilot efficacy and tolerability: A randomized, placebo‐controlled trial of levetiracetam for essential tremor. https://app.cochat.ai/papers/10.1002/mds.20147
- The paper
- Handforth, A., & Martin, F. C. (2004). Pilot efficacy and tolerability: A randomized, placebo‐controlled trial of levetiracetam for essential tremor. Movement Disorders. https://doi.org/10.1002/mds.20147
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.